[PDF] SUPPLEMENT S2: RT-QPCR METHODS - Free Download PDF (2024)

1 SUPPLEMENT S2: RT-QPCR METHODS Table S2.1 Experimental design Definition of experimental and control groups Number in ...

SUPPLEMENT S2: RT-QPCR METHODS Table S2.1 – Experimental design Definition of experimental and control groups Number in each group Assay carried out by core or investigator's laboratory

Experimental: Madison (MSN) mouse strain. Control: outbred hsd:ICR (ICR) mouse strain. 8 MSN, 8 ICR. All mice were male.

Authors’ contributions to qPCR section

C. Michael Saul: all molecular work, half of dissection work, writing. Griffin M. Gessay: half of dissection work. Stephen C. Gammie: bred mice, provided funding and lab space, writing.

Carried out in investigator's laboratory.

Table S2.2 – Tissue Samples Description Volume or Mass of sample Dissection Type Processing Procedure If frozen, how quickly? Sample storage conditions

Fresh frozen whole hippocampus. See table S2.10. Gross dissection of hippocampal tissue from brain. Animals were euthanized by cervical dislocation under isoflurane anesthetic, decapitated, and their hippocampi were immediately dissected from their brains. Samples frozen immediately on dry ice upon dissection. Stored at -80°C for no more than 12 weeks prior to RNA extraction.

Table S2.3 – Nucleic Acid Extraction Procedure and/or instrumentation Name of kit and details of any modifications Sources of additional reagents used

Mortar and pestle disruption, guanidinium thiocyanate-phenol-chloroform extraction, and spin column cleanup and purification. Bio-Rad Aurum Total RNA Fatty and Fibrous Tissue Kit (catalog number 7326830) used according to the manufacturer’s specifications. Chloroform (Acros Organics, catalog number AC42355-0250) Ethanol (Fisher Scientific, catalog number BP2818-500)

Details of DNase treatment

On-column treatment with DNase I according to manufacturer's specifications.

Contaminaion assessment of input RNA

NanoDrop curves used to assess presence of presence of protein, salt, and organic contaminants. All curves indicated clean samples.

Nucleic acid quantification

See table S2.10.

Instrument and method of nucleic acid quantification

NanoDrop spectrophotometer, absorbance at 260nm.

Purity (A260/A280)

See table S2.10.

Yield

See table S2.10.

RNA integrity instrument

Agilent RNA 6000 Nano Chips with Agilent BioAnalyzer 2100.

RIN

See table S2.10.

Inhibition testing

Cq dilution, 1:8 using Ywhaz. As expected, diluted samples ran ~3 cycles behind undiluted samples.

Table S2.4 – Reverse Transcription Complete reaction conditions Amount of RNA and reaction volume Priming oligonuclotide and concentration Temperature and time Manufacturer of reagents and catalog number Cq with and without RT Storage conditions of cDNA

500µM dNTP mix, 20mM Tris-HCl (pH 8.4), 50mM KCl, 5mM MgCl2, 2.5mM dT 20mers, 10mM DTT, 2U/µL RNaseOUT, 10U/µL SuperScript III RT. 25µL reactions, 2µg total RNA used in each reaction. 1.25µL RNAse H added after reaction termination. oligo-dT 20mers, final reaction concentration of 2.5mM. Prior to cDNA synthesis, RNA, primers, and dNTPs were denatured together at 65°C for 5 min. cDNA synthesis took place at 50°C for 50 min followed by an 85°C reaction termination step for 5 min. After reaction termination, the RNase reaction ran at 37°C for 20 min. Invitrogen SuperScript III First-Strand Synthesis System for RT-PCR (catalog number 18080-051) See table S2.10 for no RT Cqs. While some gDNA contamination is present, its effect on experiments are negligible and stochastic according to hypothesis testing on no RT controls. This contamination is mostly a source of random error. Stored at -80°C for no longer than 6 months.

Table S2.5 – qPCR Target Information Gene symbol

See table S2.11.

Accession number

See table S2.11.

Location of amplicon

See table S2.11.

Amplicon length

See table S2.11.

In silico specificity

All primers screened for specificity using NCBI Primer-BLAST.

hom*ologs amplified

No primers amplified pseudogenes or retropseudogenes.

Sequence alignment

Aligned in NCBI Primer-BLAST.

Location of each primer by exon or intron

See table S2.11.

Targeted splice variants

Each primer set targets all splice variants for every transcript of interest as they are documented in the NCBI RefSeq RNA database.

Table S2.6 – qPCR oligonucleotides Primer sequences

See table S2.11.

Probe sequences

Not applicable; dsDNA binding dye chemistry used.

Location and identity of any modifications Manufacturer of oligonucleotides Purification method

No modifications. UW-Madison Biotechnology Center DNA Synthesis Facility. Standard desalting and lyophilization.

Table S2.7 – qPCR protocol Complete reaction conditions

2X Bio-Rad SsoFast EvaGreen Super Mix without ROX (catalog number 1725204) used with no modifications.

Reaction volume and amount of cDNA/DNA

20µL reactions; 2µL 1:5 diluted cDNA used in each reaction.

Primer Concentration

500nM forward and 500nM reverse primer for all primer sets.

Mg2+concentration

3.0mM MgCl2.

dNTP concentration

200µM each of dATP, dTTP, dCTP, and dGTP. 800µM dNTP total.

Polymerase identity

Bio-Rad SsoFast Taq Fusion Polymerase.

Polymerase concentration

Proprietary concentration.

Buffer identity and manufacturer

Bio-Rad qPCR buffer provided with SsoFast EvaGreen Supermix.

Exact buffer chemistry

Proprietary composition.

PCR additives used

No additives used.

Manufacturer of plates and catalog number

Applied Biosystems MicroAmp Fast 96-Well Reaction Plates (catalog number 4346907). Incubation stage: 30s at 95°C. Cycling stage: 40 cycles, 3 steps: 5s at 95°C, 20s at annealing temperature (see table S2.11 for the specific annealing temperature used with each primer set), and 20s at 72°C.

Complete thermal cycling parameters Reaction setup

Manual using Eppendorf single channel adjustable volume pipettes.

qPCR instrument

Applied Biosystems StepOnePlus.

Table S2.8 – qPCR validation Evidence of optimization Specificity Cq of NTC Calibration curves with slope and y-intercept (m, b) Efficiency calculated from slope

Prior to analysis, we ran each primer set at several annealing temperatures. We used the annealing temperature with the earliest Cq and the highest efficiency. Stringent in silico testing of primers prior to qPCR using Primer-BLAST, dissociation curve test of specificity in vitro. Cq > 40 for all NTCs for all genes. See table S2.12. See table S2.12.

r2 of calibration curve

See table S2.12.

Linear dynamic range (LDR)

See table S2.12.

Cq variation at Limit of Detection

LOD measurements not necessary for relative quantification.

Evidence for LOD

LOD measurements not necessary for relative quantification.

If multiplex, efficiency and LOD for each assay

Not applicable; dsDNA binding dye chemistry used.

Table S2.9 – Data analysis qPCR analysis program

Relative Expression Software Tool (REST)

Method of Cq determination

Used ABI StepOnePlus software to determine ABI’s Ct value.

Outlier identification and disposition

Our experiments contain no outliers.

Results from NTC

All NTCs have no amplification.

Justification of number and choice of reference genes

The combination of Sdha and Ywhaz was found to be the most stable combination of reference genes by Gubern et al. (2009).

Description of normalization

Data normalized for baseline fluorescence.

Number and stage (reverse transcription or qPCR) of technical replicates Statistical methods for results significance Software (source, version) of stats

3 qPCR technical replicates. Randomization test for significance. StepOnePlus 2.1; REST 2009.

Table S2.10 – Sample quality control

ID

Strain

Tissue Mass

RNA Concentration

RNA Yield

Cq (RT/no RT)†

A260 : A280

RIN

1

MSN

35.8 mg

222.34 ng/µL

35.574 µg

18.20/36.78*

2.11

8.2

*

2.12

8.3

2

MSN

36.7 mg

248.83 ng/µL

39.813 µg

17.84/40.00

3

MSN

35.7 mg

271.41 ng/µL

43.426 µg

18.01/31.40

1.99

8.3

*

2.12

8.2

4

MSN

35.8 mg

235.50 ng/µL

37.680 µg

17.75/38.96

5

MSN

60.0 mg

454.53 ng/µL

72.725 µg

18.09/36.62

2.08

8.4

6

MSN

48.2 mg

331.09 ng/µL

52.974 µg

17.88/35.23

2.11

8.2

7

MSN

41.0 mg

290.64 ng/µL

46.502 µg

17.83/38.10*

2.11

8.5

*

2.11

8.3

8

MSN

46.0 mg

263.10 ng/µL

42.096 µg

17.78/38.97

9

ICR

50.7 mg

347.06 ng/µL

55.530 µg

18.03/34.77

2.09

8.5

10

ICR

32.2 mg

215.83 ng/µL

34.533 µg

17.66/36.45

2.12

8.2

11

ICR

44.2 mg

261.85 ng/µL

41.896 µg

17.77/33.17

2.13

8.3

*

2.12

8.3

12

ICR

38.2 mg

247.66 ng/µL

39.626 µg

17.83/39.20

13

ICR

42.0 mg

278.96 ng/µL

44.634 µg

17.97/37.30*

2.11

8.9

*

2.12

8.7

14

ICR

37.2 mg

274.48 ng/µL

43.917 µg

17.98/38.91

15

ICR

30.7 mg

236.85 ng/µL

37.896 µg

17.83/36.06

2.12

9.2

16

ICR

43.3 mg

288.02 ng/µL

46.083 µg

18.02/35.53

2.12

9.4

RT versus no RT data were collected using the reference gene Ywhaz. Cq = 40 indicates no amplification detected.

*No amplification was detected in at least 1 of the replicates in these no RT controls.

Table S2.11 – Primers Gene Symbol

RefSeq Accession

Ywhaz

NM_01174

Sdha

NM_02328

P2x7

NM_011027

Epor

NM_010149

Fhit

NM_010210

Cmklr1

NM_00815

Npsr1

NM_175678

Tac1

NM_009311

Cat

NM_009804

Product Length

Primer Sequence (5’-3’) F: TCCTTATTCCCTCTTGGCAG R: ATGGAAGCTACATTAGCGGTTT F: CCGCTCCTACTGATGAAACC R: GCGCAACTCAATCCCTTAC F: CGAATTATGGCACCGTCAA R: TCTCCGTCACCTCTGCTATG F: GTCCGATTCTGGCATCTCA R: GGACAAGGCTGTTCTCATAG F: CAAACGATTCCCAAGGCATAA R: GGGTACAATAAAGAGTGGTTAG F: ATCTTACACCATCATGCCACG R: GTATACACACTGAAGCAAAGAGC F: GTAGAGGAGCCAATTAACAAGTA R: TAGACCAGAACTTGACAGAGAT F: ACGCACTATCTATTCATCTTCATC R: AGAATTACAAGGCTTATTGGCA F: TTCCCACTTGGATTATGTTGATG R: CTGAAAGCAACCAAACACGG

92 bp 179 bp 150 bp 107 bp 89 bp 95 bp 106 bp 167 bp 119 bp

Amplicon Location Exon 5; 2432-2523 (3’ UTR) Exon 12; 2015-2193 (ORF, 3’ UTR) Exons 1, 2; 234-383 (ORF) Exon 8; 1519-1625 (ORF) Exon 7; 697-763 (3’ UTR) Exon 3; 2003-2097 (3’ UTR) Exon 10; 2866-2971 (3’ UTR) Exon 7; 502-668 (3’ UTR) Exon 13; 2358-2476 (3’ UTR)

Tm 58°C 58°C 57°C 58°C 58°C 58°C 57°C 58°C 56°C

Table S2.12 – qPCR quality control Gene Symbol

PCR Efficiency

Linear Dynamic Range

r2

Slope

y Intercept

Ywhaz Sdha P2x7 Epor Fhit Cmklr1 Npsr1 Tac1 Cat

98.375% 97.271% 96.354% 99.573% 104.902% 98.375% 99.305% 97.414% 97.228%

Cq: 17.60-27.71 Cq: 17.97-28.19 Cq: 27.06-33.29 Cq: 25.42-31.47 Cq: 26.25-33.86 Cq: 27.92-35.92 Cq: 30.68-34.69 Cq: 23.69-29.79 Cq: 28.24-34.31

0.998 0.998 0.989 0.998 0.990 0.994 0.989 0.997 0.987

-3.362 -3.389 -3.412 -3.332 -3.210 -3.362 -3.339 -3.385 -3.390

25.020 25.472 34.583 32.743 33.346 35.382 38.136 31.181 35.793

[PDF] SUPPLEMENT S2: RT-QPCR METHODS - Free Download PDF (2024)
Top Articles
Latest Posts
Article information

Author: Saturnina Altenwerth DVM

Last Updated:

Views: 6193

Rating: 4.3 / 5 (44 voted)

Reviews: 83% of readers found this page helpful

Author information

Name: Saturnina Altenwerth DVM

Birthday: 1992-08-21

Address: Apt. 237 662 Haag Mills, East Verenaport, MO 57071-5493

Phone: +331850833384

Job: District Real-Estate Architect

Hobby: Skateboarding, Taxidermy, Air sports, Painting, Knife making, Letterboxing, Inline skating

Introduction: My name is Saturnina Altenwerth DVM, I am a witty, perfect, combative, beautiful, determined, fancy, determined person who loves writing and wants to share my knowledge and understanding with you.